Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and Bevacizumab

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02330562
Recruitment Status : Active, not recruiting
First Posted : January 5, 2015
Last Update Posted : October 1, 2019
Sponsor:
Collaborator:
Triphase
Information provided by (Responsible Party):
Celgene

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 10, 2019
Estimated Study Completion Date : December 10, 2019